Prophylactic efficacy of the mucosal cytoprotective agent teprenone and the proton pump inhibitor rabeprazole against gastroduodenal lesions caused by piroxicam: controlled trial study.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.